- Home
- RVSB vs GNTA Comparison
RVSB vs GNTA Comparison
Compare RVSB & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVSB | GNTA |
|---|---|---|
| Founded | 1923 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.8M | 34.0M |
| IPO Year | 1993 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RVSB | GNTA |
|---|---|---|
| Price | $5.03 | $1.46 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 46.5K | ★ 92.8K |
| Earning Date | 01-29-2026 | 03-30-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | ★ 361.12 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $52,756,000.00 | N/A |
| Revenue This Year | $10.25 | N/A |
| Revenue Next Year | $11.23 | N/A |
| P/E Ratio | $22.87 | ★ N/A |
| Revenue Growth | ★ 15.20 | N/A |
| 52 Week Low | $4.74 | $1.28 |
| 52 Week High | $6.59 | $10.00 |
Technical Indicators
Market Signals| Indicator | RVSB | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 36.07 |
| Support Level | $5.01 | $1.28 |
| Resistance Level | $5.62 | $1.68 |
| Average True Range (ATR) | 0.16 | 0.17 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 4.92 | 27.42 |
Price Performance
Historical ComparisonAbout RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.